Aflac (NYSE:AFL) Price Target Cut to $81.00

Aflac (NYSE:AFL) had its target price lowered by research analysts at Wells Fargo & Company from $83.00 to $81.00 in a research note issued on Thursday, Benzinga reports. The firm currently has an “equal weight” rating on the financial services provider’s stock. Wells Fargo & Company‘s price objective would indicate a potential upside of 0.90% from the stock’s previous close.

Other equities analysts have also issued research reports about the stock. The Goldman Sachs Group lifted their price target on shares of Aflac from $61.00 to $75.00 and gave the company a “sell” rating in a research report on Tuesday, January 9th. Morgan Stanley dropped their target price on shares of Aflac from $85.00 to $80.00 and set an “equal weight” rating on the stock in a research report on Friday, March 1st. Evercore ISI lowered shares of Aflac from an “in-line” rating to an “underperform” rating and boosted their target price for the stock from $76.00 to $78.00 in a research report on Thursday, January 4th. Piper Sandler boosted their target price on shares of Aflac from $90.00 to $95.00 and gave the stock an “overweight” rating in a research report on Friday, April 5th. Finally, StockNews.com lowered shares of Aflac from a “hold” rating to a “sell” rating in a research report on Wednesday. Three investment analysts have rated the stock with a sell rating, eight have issued a hold rating and three have given a buy rating to the stock. According to MarketBeat, Aflac has a consensus rating of “Hold” and a consensus price target of $81.85.

Aflac Trading Up 0.8 %

NYSE:AFL opened at $80.28 on Thursday. Aflac has a 12 month low of $64.10 and a 12 month high of $86.26. The firm has a market cap of $46.19 billion, a price-to-earnings ratio of 10.36, a P/E/G ratio of 2.27 and a beta of 0.91. The company has a quick ratio of 0.06, a current ratio of 0.06 and a debt-to-equity ratio of 0.33. The company’s 50 day moving average is $81.88 and its 200-day moving average is $81.36.

Aflac (NYSE:AFL) last released its quarterly earnings results on Thursday, February 1st. The financial services provider reported $1.25 EPS for the quarter, missing analysts’ consensus estimates of $1.47 by ($0.22). Aflac had a net margin of 24.92% and a return on equity of 17.59%. The firm had revenue of $3.78 billion during the quarter, compared to the consensus estimate of $4.44 billion. During the same period in the prior year, the business earned $1.29 EPS. Equities analysts anticipate that Aflac will post 6.43 EPS for the current year.

Insider Buying and Selling at Aflac

In other Aflac news, SVP Albert Riggieri sold 8,000 shares of the business’s stock in a transaction on Thursday, March 14th. The shares were sold at an average price of $83.34, for a total value of $666,720.00. Following the sale, the senior vice president now owns 32,825 shares of the company’s stock, valued at approximately $2,735,635.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other news, Director Masatoshi Koide sold 30,493 shares of the business’s stock in a transaction on Friday, February 16th. The shares were sold at an average price of $79.91, for a total value of $2,436,695.63. Following the sale, the director now owns 86,090 shares in the company, valued at approximately $6,879,451.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Albert Riggieri sold 8,000 shares of the business’s stock in a transaction on Thursday, March 14th. The shares were sold at an average price of $83.34, for a total transaction of $666,720.00. Following the completion of the sale, the senior vice president now owns 32,825 shares in the company, valued at approximately $2,735,635.50. The disclosure for this sale can be found here. Insiders have sold 46,493 shares of company stock valued at $3,765,706 in the last 90 days. 0.90% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Aflac

Several institutional investors and hedge funds have recently made changes to their positions in the company. Riverview Trust Co acquired a new stake in shares of Aflac in the 1st quarter valued at $100,000. Jacobs & Co. CA acquired a new stake in shares of Aflac in the 1st quarter valued at $204,000. Unison Advisors LLC boosted its stake in shares of Aflac by 0.6% in the 1st quarter. Unison Advisors LLC now owns 45,105 shares of the financial services provider’s stock valued at $3,873,000 after purchasing an additional 278 shares in the last quarter. Global Assets Advisory LLC acquired a new stake in shares of Aflac in the 1st quarter valued at $1,512,000. Finally, Lloyd Advisory Services LLC. acquired a new position in Aflac during the 1st quarter worth about $1,415,000. Institutional investors and hedge funds own 67.44% of the company’s stock.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.